pqq cofactor has been researched along with rotenone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Ding, F; Jiang, C; Ke, K; Qin, J; Zhang, J; Zhang, Q | 1 |
Gattupalli, NK; Pandey, SK; Saha, G; Singh, AK | 1 |
Ding, F; Dong, X; Gao, X; Ji, J; Qin, J; Wu, M; Yu, S; Zhang, J; Zhang, Q; Zhang, Y; Zhou, L | 1 |
Chen, S; Cheng, Q; Ding, F; Ke, K; Qin, J; Yu, S; Zhang, J; Zhang, Q | 1 |
Chen, S; Ding, F; He, Q; Lu, J; Shen, M; Shi, Y; Zhang, Q; Zhang, Y | 1 |
Chen, J; Cheng, Q; Ding, F; Guo, H; Guo, XY; Lu, JL; Shi, Y; Yu, S; Zhang, Q; Zhang, Y; Zhou, J | 1 |
Cheng, Q; Ding, F; Shen, M; Xu, H; Yu, S; Zhang, Q; Zhou, J | 1 |
7 other study(ies) available for pqq cofactor and rotenone
Article | Year |
---|---|
Involvement of ERK1/2 pathway in neuroprotective effects of pyrroloquinoline quinine against rotenone-induced SH-SY5Y cell injury.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Survival; DNA, Mitochondrial; Electron Transport Complex I; Glutathione; Humans; Malondialdehyde; MAP Kinase Signaling System; Mitochondria; NADH Dehydrogenase; Neuroprotective Agents; Parkinsonian Disorders; PQQ Cofactor; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Rotenone; Superoxide Dismutase | 2014 |
Pyrroloquinoline quinone (PQQ) producing Escherichia coli Nissle 1917 (EcN) alleviates age associated oxidative stress and hyperlipidemia, and improves mitochondrial function in ageing rats.
Topics: Aging; Animals; Antioxidants; Escherichia coli; Glutathione; Hyperlipidemias; Lipid Peroxidation; Male; Mitochondria; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PQQ Cofactor; Rats; Reactive Oxygen Species; Rotenone; Succinate Dehydrogenase; Superoxide Dismutase; Transcription Factors | 2015 |
Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Gene Expression Regulation; Glutathione; Humans; Malondialdehyde; Neuroprotective Agents; Parkinson Disease, Secondary; PQQ Cofactor; Rats; Rotenone; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2015 |
Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson's disease.
Topics: Animals; Cell Line, Tumor; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mesencephalon; Neurons; Neuroprotective Agents; Parkinson Disease; PQQ Cofactor; Rats; Rats, Sprague-Dawley; Rotenone; Treatment Outcome | 2016 |
Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Insecticides; Mitochondria; Parkinsonian Disorders; PQQ Cofactor; Rats; Rats, Sprague-Dawley; Rotenone | 2018 |
Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson's disease model via AMPK activation.
Topics: AMP-Activated Protein Kinases; Animals; Behavior, Animal; Cell Line, Tumor; Humans; Locomotion; Male; Mice, Inbred ICR; Mitochondria; Nerve Tissue Proteins; Neuroprotective Agents; Organelle Biogenesis; Parkinson Disease, Secondary; Phosphorylation; PQQ Cofactor; Rotenone; Signal Transduction | 2021 |
Pyrroloquinoline Quinone Inhibits Rotenone-Induced Microglia Inflammation by Enhancing Autophagy.
Topics: Anti-Inflammatory Agents; Autophagy; Cell Line, Tumor; Cell Survival; Humans; Inflammation; Microglia; Neuroprotective Agents; PQQ Cofactor; Rotenone | 2020 |